Call for Abstract
Scientific Program
26th International Conference on Advanced Clinical Research and Clinical Trials, will be organized around the theme “”
Clinical Research 2020 is comprised of 20 tracks and 101 sessions designed to offer comprehensive sessions that address current issues in Clinical Research 2020.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Vertebrate and invertebrate vision
- Track 1-2Advancements in Imaging Research
- Track 1-3Roles of Nurses in Research
- Track 1-4Purposes of Nursing Research
- Track 1-5History of Nursing Research
- Track 1-6Promote Evidence-Based Nursing Practice
- Track 2-1Advanced research in stem Cells
- Track 2-2Clinical Trials in Cancer Pharma Industry
- Track 2-3Discussion on latest research in Molecular Biology
- Track 2-4Innovations in Genetic research
- Track 2-5Innovative Methods in Embryology Research
- Track 2-6Research in connective, muscle, nervous and epithelial tissues
Includes setting desires, being sorted out and building up measurements to track execution, and building and fortifying associations with following destinations like Identify instruments for site distinguishing proof, assessment and choice, Discuss techniques for enhancing the site/support/CRO relationship, Discuss best practices for guaranteeing general investigation achievement The site is typically a doctor's facility or a comparable human services foundation that has satisfactory framework and staff to meet the necessities of the clinical trial convention. A related administrations to an agreement explore association (CRO), a pharmaceutical organization, a biotechnology organization, a restorative gadget organization or a clinical site. The site is normally a doctor's facility or a comparable <span -webkit-text-stroke-width:="" display:="" float:="" font-family:="" font-size:="" font-style:="" font-variant-caps:="" font-variant-ligatures:="" font-weight:="" inline="" letter-spacing:="" new="" orphans:="" span="" style="\" color:"="" text-align:="" text-decoration-color:="" text-decoration-style:="" text-indent:="" text-transform:="" times="" white-space:="" widows:="" word-spacing:=""> services foundation that has sufficient framework and staff to meet the prerequisites of the clinical trial convention.
- Track 3-1Consent Documents and Assent Documents
- Track 3-2Conduct Regular Meetings during Start-up
- Track 3-3Scientific or Local Research Committee
- Track 3-4Clinical Site Monitoring Plan
- Track 3-5Institutional Review Board
- Track 4-1Priorities and needs of PV at different stages of a product life-cycle
- Track 4-2Challenges and opportunities in PV lifecycle management
- Track 4-3IT solutions for pharmacovigilance
- Track 4-4Safety surveillance and risk management life cycle
- Track 5-1Informed Consent
- Track 5-2MOP Template and Mechanics
- Track 5-3Purpose of the Manual of Procedures
- Track 5-4Safety definitions for clinical research
Oncology is a branch of prescription that arrangements with tumours. A therapeutic expert who hones oncology is an oncologist. Integrative oncology deals with the brain, body, and soul. Modalities of development, touch, nourishment, and care are utilized inside routine disease care to address and enhance indications and personal satisfaction. That is the reason numerous experts, including medicinal specialists, have grasped the quickly extending field of integrative oncology, which melds the best of customary and option medications. Immuno-oncology treatments enact our invulnerable framework, making it ready to perceive growth cells and annihilate them. Since tumour cells are altogether different from ordinary cells in the body, the resistant framework assaults them when it can remember them. Neuro-oncology assesses and treats individuals with essential and optional tumours of the cerebrum, spinal line, and the layers encompassing the mind and spinal rope (meninges). Oncologic Emergencies, as the term infers, are difficulties coming about because of a growth itself, a paraneoplastic disorder, or from treatment of malignancy that require prompt consideration and inversion, if conceivable. Inpatient treatment is an absolute necessity, and frequently these conditions require intercession in an escalated mind setting.
- Track 6-1Pediatric Oncology
- Track 6-2Hematology Oncology in Clinical Research
- Track 6-3Cancer: Diagnostics and Staging
- Track 6-4Cancer and Pharmacology
- Track 7-1Antigen and antibody Reactions
- Track 7-2Culture Media and Culture Methods
- Track 7-3Evolution of microbiology
- Track 7-4Methods of studying bacteria
- Track 8-1Animal Models for Human Diseases
- Track 8-2Databases for Biomedical Animal Resources
- Track 8-3Improved Models for Animal Research
- Track 8-4The Ethical Basis for Animal Use in Research
- Track 9-1Phases of clinical trials
- Track 9-2Innovations in patient and community engagement in clinical trials
- Track 9-3Data monitoring for trials with an adaptive design
- Track 9-4Heterogeneity of treatment effect in randomized clinical trials
- Track 9-5Treating different ailments by clinical trials
- Track 9-6Pre-clinical research leading to clinical trials
- Track 9-7The good, the bad and the ugly of clinical trials
- Track 10-1Design for predictive bio marker validation
- Track 10-2Innovative approaches to patient recruitment
- Track 10-3Innovative partnering in clinical research
- Track 10-4Randomized placebo- controlled trials
- Track 11-1Latest technologies to Formulate a Testable Hypothesis
- Track 11-2Psychology: A Concise Introduction
- Track 11-3Unity and diversity of psychology research
- Track 11-4Psychological Measurement
- Track 12-1Embracing the clinical trial of the future
- Track 12-2Designing the clinical trial of the future
- Track 12-3Cloud based medical image management for clinical trials
- Track 12-4Clinical development of the future
- Track 12-5Clinical trial site of the future
- Track 12-6Mobile technology
- Track 12-7Paperless Clinical Trials
- Track 13-1Epidemiology and Community Health
- Track 13-2Epidemiology and Health Prevention
- Track 13-3Epidemiology and Mental Health
- Track 13-4Epidemiology and Risk factor
- Track 13-5Public Health administration
- Track 14-1Design and end points of clinical trials
- Track 14-2Trial design: formulation development, manufacturing and analytical testing
- Track 14-3Observational study designs
- Track 14-4Experimental Study designs
- Track 14-5Randomized Clinical Trials
- Track 14-6Adaptive Clinical Trials
- Track 15-1Clinical trials on rare diseases
- Track 15-2Medical Devices Clinical Trials
- Track 15-3Research and Studies on wounds and injuries
- Track 15-4Research and Trials on Human Cells
- Track 15-5Research in Pathology
Clinical research concentrates that investigate whether a restorative methodology, treatment, or gadget is protected and successful for people. Ponder indicate which medicinal methodologies work best for specific sicknesses or gatherings of individuals. The reason for clinical trials is research, so the reviews take after strict logical gauges. These guidelines secure patients and deliver dependable review comes about. Clinical research is one of the last phases of a long and cautious research handle. Clinical trials are directed for each malady. The primary purpose behind doing trials is to figure out if one treatment is superior to another, 19% by and large increment in number of enlistment every year in Clinical Trials, 47.0% expansion in Market Investment in Clinical Trials from 2013-2015
- Track 16-1Asia Clinical Trials
- Track 16-2Globalization of Clinical Trials
- Track 16-3Canada Clinical Trials
- Track 16-4Japan Clinical Trials
- Track 16-5Europe Clinical Trials
- Track 16-6USA Clinical Trials
- Track 16-7UK Clinical Trials
- Track 17-1Advanced products in data management
- Track 17-2Advanced products in data management
- Track 17-3Bayesian data analysis
- Track 17-4Data types and data processing techniques
- Track 17-5Sequential treatment factors for controlled trials
- Track 18-1Case reports dealing with the use of novel technologies
- Track 18-2Case reports in neurology, ophthalmology, obstetrics and gynecology
- Track 18-3Case reports in oncology, diabetes and cardiovascular diseases
- Track 18-4Dermatology, gastroenterology, Nephrology, pulmonology and urology case reports
- Track 19-1Building an action plan in CTS
- Track 19-2Fundamentals of outsourcing in clinical devices
- Track 19-3Globalization & Outsourcing
- Track 19-4Strategic or tactical outsourcing
- Track 20-1Compliance and regulatory requirements in clinical research
- Track 20-2Compliance and regulatory requirements in clinical research
- Track 20-3Ethical and regulatory issues
- Track 20-4Ethics & Human Subject Protection
- Track 20-5Regulatory Inspections of Research Sites
- Track 20-6Techniques for designing case report forms in clinical research
